cyclohexanol has been researched along with am 630 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernando, S; Griffin, G; Hill, A; Li, X; Makriyannis, A; Pertwee, R | 1 |
| Brockie, HC; Makriyannis, A; Murphy, VL; Pertwee, RG; Ross, RA; Stevenson, LA; Templeton, F | 1 |
| Adams, M; Cassar, S; Daza, A; Kage, K; Meyer, M; Mukherjee, S; Whiteaker, K; Yao, BB | 1 |
| Mayeux, PR; Prather, PL; Ruckle, MB; Shoemaker, JL | 1 |
| Ganju, RK; Ghosh, S; Groopman, JE; Preet, A | 1 |
| Fowler, CJ; Jacobsson, SO; Nilsson, O | 1 |
| Bingham, B; Chlenov, M; Cummons, TA; Harrison, JE; He, Y; Jones, PG; Kennedy, JD; Kotnis, S; Lu, P; Piesla, MJ; Resnick, L; Smith, VA; Strassle, BW; Sun, SC; Uveges, AJ; Whiteside, GT | 1 |
| Araújo, JR; Azevedo, I; Gonçalves, P; Martel, F | 1 |
| Araújo, JR; Gonçalves, P; Martel, F | 1 |
| Beltramo, M; Brusa, R; Foglia, C; Mancini, I; Quadrato, G; Reggiani, A; Scandroglio, P; Silverman, LS; Tulshian, D | 1 |
| Beltramo, M; Brusa, R; Lozza, G; Mancini, I; Petrò, R; Reggiani, A; Scandroglio, P | 1 |
| Codd, EE; Flores, CM; Mabus, JR; Murray, BS; Zhang, SP | 1 |
| Bolognini, D; Cascio, MG; Parolaro, D; Pertwee, RG | 1 |
| Funada, M; Tomiyama, K | 1 |
| Bakali, E; Elliott, RA; Lambert, DG; Mason, R; Mbaki, Y; Tincello, DG | 1 |
| Ford, BM; Franks, LN; Prather, PL; Radominska-Pandya, A | 1 |
16 other study(ies) available for cyclohexanol and am 630
| Article | Year |
|---|---|
AM630, a competitive cannabinoid receptor antagonist.
Topics: Animals; Arachidonic Acids; Benzoxazines; Binding, Competitive; Cannabinoids; Cyclohexanols; Endocannabinoids; In Vitro Techniques; Indoles; Male; Mice; Morpholines; Naphthalenes; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug | 1995 |
Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
Topics: Animals; Benzoxazines; Binding, Competitive; Camphanes; Cannabinoids; CHO Cells; Chromans; Colforsin; Cricetinae; Cyclic AMP; Cyclohexanols; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Morpholines; Naphthalenes; Pyrazoles; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Tritium | 1999 |
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors.
Topics: Animals; Arachidonic Acids; Benzoxazines; Binding, Competitive; Calcium; Cell Line; Chromones; Colforsin; Cyclic AMP; Cyclohexanols; DNA, Complementary; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Humans; Indoles; Morpholines; Naphthalenes; Polyunsaturated Alkamides; Radioligand Assay; Rats; Receptor, Cannabinoid, CB2; Species Specificity; Transfection; Tritium | 2004 |
Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
Topics: Adenylyl Cyclases; Animals; Arachidonic Acids; Binding, Competitive; Blotting, Western; Calcium Signaling; Cannabinoid Receptor Modulators; Cell Membrane; CHO Cells; Cricetinae; Cyclic AMP; Cyclohexanols; DNA, Complementary; Endocannabinoids; Enzyme-Linked Immunosorbent Assay; Glycerides; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Indoles; Mitogen-Activated Protein Kinases; Receptor, Cannabinoid, CB2; Transfection | 2005 |
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.
Topics: Calcium; Cannabinoids; Chemokine CXCL12; Chemokines, CXC; Chemotaxis, Leukocyte; Cyclohexanes; Cyclohexanols; Endothelium, Vascular; Humans; Immunosuppressive Agents; Indoles; Jurkat Cells; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinases; Phenols; Receptor, Cannabinoid, CB2; Receptors, CXCR4; Signal Transduction; T-Lymphocytes; Umbilical Veins | 2006 |
The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
Topics: Analysis of Variance; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cell Line; Cell Movement; Chemotaxis; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Endothelial Cells; Flow Cytometry; Humans; Indoles; Interleukin-8; L-Lactate Dehydrogenase; Morpholines; Naphthalenes; Neutrophils; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Thapsigargin; Tumor Necrosis Factor-alpha | 2006 |
Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.
Topics: Analgesics; Animals; Benzoxazines; Calcium Channel Blockers; Camphanes; Cannabinoids; Carrageenan; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Hyperalgesia; Indoles; Mice; Morpholines; Naphthalenes; Protein Binding; Pyrazoles; Radioligand Assay; Rats; Receptor, Cannabinoid, CB2; Species Specificity; Stereoisomerism; Tritium | 2007 |
Lack of a significant effect of cannabinoids upon the uptake of 2-deoxy-D-glucose by Caco-2 cells.
Topics: Arachidonic Acids; Caco-2 Cells; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Cyclohexanols; Deoxyglucose; Dronabinol; Endocannabinoids; Humans; Indoles; Intestinal Absorption; Piperidines; Polyunsaturated Alkamides; Pyrazoles | 2008 |
Effect of cannabinoids upon the uptake of folic acid by BeWo cells.
Topics: Arachidonic Acids; Carrier Proteins; Cell Culture Techniques; Cell Line, Tumor; Cyclohexanols; Dronabinol; Drug Administration Schedule; Endocannabinoids; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hydrogen-Ion Concentration; Indoles; Membrane Transport Proteins; Piperidines; Placenta; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cell Surface | 2009 |
Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242.
Topics: Animals; Cannabinoids; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Indoles; Rats; Receptor, Cannabinoid, CB2 | 2009 |
Evaluation of cannabinoid receptor 2 and metabotropic glutamate receptor 1 functional responses using a cell impedance-based technology.
Topics: Analgesics; Animals; Benzimidazoles; Biological Assay; Calcium; Cannabinoids; CHO Cells; Chromones; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Cycloleucine; Electric Impedance; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Indoles; Naphthalenes; Neuroprotective Agents; Quinolines; Quisqualic Acid; Receptor, Cannabinoid, CB2; Receptors, Metabotropic Glutamate; Resorcinols; Signal Transduction; Thiazoles | 2010 |
Dynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptors.
Topics: Analgesics, Opioid; Animals; Butadienes; Cannabinoids; Carrier Proteins; Chemistry Techniques, Analytical; CHO Cells; Cricetinae; Cyclohexanols; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; GTP-Binding Protein alpha Subunits; Indoles; Male; Morphine; Nitriles; Optical Phenomena; Pertussis Toxin; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, G-Protein-Coupled; Receptors, Opioid; Signal Transduction | 2011 |
AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor.
Topics: Animals; Benzoxazines; Camphanes; Cannabinoids; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Dronabinol; Humans; Indoles; Ligands; Morpholines; Naphthalenes; Pyrazoles; Radioligand Assay; Receptor, Cannabinoid, CB2 | 2012 |
Cytotoxicity of synthetic cannabinoids found in "Spice" products: the role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line.
Topics: Apoptosis; Cannabinoids; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Cyclohexanols; Cysteine Proteinase Inhibitors; Drug Interactions; Humans; Indoles; Microscopy, Fluorescence; Oligopeptides; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2011 |
Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats.
Topics: Acetic Acid; Administration, Intravesical; Animals; Cannabinoid Receptor Agonists; Cyclohexanols; Disease Models, Animal; Female; Indoles; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urination; Urodynamics | 2016 |
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development.
Topics: Adenylyl Cyclases; Animals; Binding, Competitive; Breast Neoplasms; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Isomerism; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Selective Estrogen Receptor Modulators; Tamoxifen | 2016 |